| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.00B | 55.57B | 55.21B | 51.39B | 47.87B | 41.83B |
| Gross Profit | 17.72B | 17.07B | 17.39B | 15.64B | 14.02B | 12.21B |
| EBITDA | 7.20B | 6.79B | 7.69B | 6.62B | 5.31B | 3.66B |
| Net Income | 3.23B | 3.46B | 3.63B | 3.06B | 2.06B | 995.00M |
Balance Sheet | ||||||
| Total Assets | 71.98B | 79.11B | 74.73B | 73.48B | 64.93B | 59.94B |
| Cash, Cash Equivalents and Short-Term Investments | 14.52B | 16.79B | 16.98B | 16.58B | 14.99B | 12.75B |
| Total Debt | 7.25B | 7.57B | 7.23B | 7.25B | 7.55B | 7.76B |
| Total Liabilities | 26.90B | 29.03B | 29.16B | 31.09B | 28.85B | 26.24B |
| Stockholders Equity | 42.15B | 46.94B | 42.56B | 39.35B | 33.21B | 30.79B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.92B | 2.38B | 3.08B | 4.50B | 2.87B |
| Operating Cash Flow | 0.00 | 4.08B | 3.67B | 4.46B | 5.64B | 3.78B |
| Investing Cash Flow | 0.00 | -2.17B | -1.32B | -1.43B | -2.04B | -712.00M |
| Financing Cash Flow | 0.00 | -2.29B | -2.22B | -1.50B | -1.69B | -1.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥64.99B | 11.99 | ― | 3.95% | 2.75% | 25.75% | |
80 Outperform | ¥70.53B | 12.85 | ― | 2.63% | 2.11% | 0.91% | |
79 Outperform | ¥11.26B | 8.02 | ― | 2.82% | 5.08% | 58.45% | |
74 Outperform | ¥37.72B | 10.24 | ― | 2.78% | 0.66% | -4.90% | |
66 Neutral | ¥30.60B | 14.22 | ― | 2.13% | 0.12% | 59.33% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥70.94B | 12.05 | ― | 3.09% | 7.43% | 47.68% |